title: [Arguments for early treatment of refractory schizophrenia].
abstract: The authors, taking up their experience and the literature, attempt to view the precociousness of alternative, classical neuroleptic treatments in schizophrenia, from notion of treatment-resistant schizophrenia, precocious refractory and intolerance. Until now, clozapine was administrated to patients lasting resistant and in mainly cases hospitalized since many years. As such as quality of life and economy of health, it would be desirable to quickly think of alternatives neuroleptic's therapeutic protocols and clozapine in the treatment-resistant schizophrenias or those presenting an intolerance.
authors.affiliation: Praticien hospitalier, SHU de Psychiatrie, Secteur IV, CH Esquirol, Limoges.
authors.forename: E R
authors.initials: ER
authors.lastname: Lombertie
authors.forename: N
authors.initials: N
authors.lastname: Salome
authors.forename: P
authors.initials: P
authors.lastname: Villegier
authors.forename: F
authors.initials: F
authors.lastname: Laghrissi-Thode
authors.forename: F
authors.initials: F
authors.lastname: Nassif
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D011379:Prognosis; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
chemical_list: D014150:Antipsychotic Agents
vernacular_title: Arguments pour traiter précocement les schizophrénies résistantes.